Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Tobishi Pharmaceutical Co., Ltd. Patents
Assignee:
Tobishi Pharmaceutical Co., Ltd.
Address:
Tokyo, JP
No. of patents:
10
Patents:












Patent Number Title Of Patent Date Issued
7691371 Preparation comprising batroxobin for inhibiting local invasion of malignant tumors April 6, 2010
A preparation for inhibiting local invasion of malignant tumors is provided which comprises batroxobin and therefore can inhibit local invasion of malignant tumors. A preparation for encapsulating malignant tumor tissues is also provided which comprises batroxobin and therefore can c
6399576 Method of inhibiting apoptosis June 4, 2002
A method of inhibiting apoptosis, comprising administering an effective ingredient batroxobin.
6106830 Methods for the treatment of apoptosis-related diseases by batroxobin August 22, 2000
A pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases which comprises as an effective ingredient batroxobin.
5869044 Method for the treatment or prophylaxis of ischemia-reperfusion injury February 9, 1999
Medicaments for the treatment or prophylaxis of ischemia-reperfusion injury in myocardial ischemia and cerebral ischemia, characterized in that the medicament contains batroxobin as an effective component.
5716958 Amino acid derivative having anti-CCK activity February 10, 1998
A compound represented by the formula (1): ##STR1## wherein, m is an integer of 1 to 3;n is an integer 0 or 1;A represents CH or N atom, and forms together with the N atom bonded to the carbonyl group a piperidine ring or a piperazine ring;R.sub.1 independently represents a straight or b
5595974 Medicaments for the treatment of restenosis and arterial sclerosis January 21, 1997
A medicament for the treatment and/or prophylaxis of restenosis and arterial sclerosis after percutaneous transluminal angioplasty, characterized in that the medicament contains batroxobin as an effective component.
4725578 Compounds having therapeutic effect and the preparation thereof February 16, 1988
New compounds of the following general formula: ##STR1## wherein R.sub.1 is acyl, alkyl, cycloalkyl, carboxyalkyl or ester thereof, heterocyclic group, saccharide residue or hydrogen atom, R.sub.2 stands for hydrogen atom or a lower alkyl and R.sub.3 represents hydrogen atom or a
4476299 Cyclic polyamino containing compounds having therapeutic effect and the preparation thereof October 9, 1984
New compounds of the following general formula: ##STR1## wherein R.sub.1 is acyl, alkyl, cycloalkyl, carboxyalkyl or ester thereof, heterocyclic group, saccharide residue or hydrogen atom, R.sub.2 stands for hydrogen atom or a lower alkyl and R.sub.3 represents hydrogen atom or a
4265881 Plasminogen-activating substance and the preparation and use of such substance May 5, 1981
A new type of plasminogen-activating substance is extracted from the bile of hogs, which substance is characterized by;(A) a molecular weight of 80,000 .+-.10,000;(B) an isoelectric point of 7.1;(C) an ultraviolet absorption spectrum showing a peak (.lambda. max) at a wave length of about 27
4159321 Agent for inhibiting tumor induced by leukemia virus June 26, 1979
A process for preparing an antimalignant agent which comprises cultivating Staphylococcus epidermidis STF (Bikoken(or Microbic Industry Technological Institute)Deposit No. 3706; ATCC 31310) in a liquid culture medium, removing solid matter from the culture solution, concentrating the

 
 
  Recently Added Patents
Distributed IPv6 neighbor discovery for large datacenter switching systems
Geo-coding images
Hybrid fiber constructions to mitigate creep in composites
Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
Pelvic registration device for medical navigation
Case for camera
Coding circuitry for difference-based data transformation
  Randomly Featured Patents
Memory arrangement with ordered writing particularly intended for cooperation with a radar image display unit
Chip package thermal interface materials with dielectric obstructions for body-biasing, methods of using same, and systems containing same
Current limit shutdown circuit with time delay
Herpesvirus particles comprising fusion protein and their preparation and use
Noble metal particle and process of producing the same
Organic light emitting diode display and manufacturing method thereof
Table
Oxazolidinone antibacterial agents having a thiocarbonyl functionality
Methods for carbon-centered radical mediated heavy hydrogen labeling of compounds
Imaging apparatus and method for controlling exposure by determining backlight situations and detecting a face